Android app Apple app link

Gilead Sciences, Inc. (GILD) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$143.49
Day's range
$146.77

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
06/01/2026 RBC Capital Brian Abrahams $122.00 $134.43   -9.25%
05/20/2026 Maxim Group Michael Okunewitch $165.00 $130.55   26.39%
04/08/2026 Truist Financial Gregory Renza $155.00 $141.54   9.51%
03/10/2026 Jefferies Akash Tewari $180.00 $146.94   22.5%
02/11/2026 Scotiabank Louise Chen $177.00 $155.29   13.98%
02/11/2026 Bernstein Courtney Breen $160.00 $155.45   2.93%
02/11/2026 Needham Joseph Stringer $170.00 $154.09   10.33%
02/11/2026 BMO Capital Evan Seigerman $160.00 $147.23   8.67%
02/11/2026 Wells Fargo Mohit Bansal $165.00 $147.23   12.07%
01/26/2026 BMO Capital Evan David Seigerman $150.00 $137.01   9.48%
01/07/2026 UBS Michael Yee $145.00 $121.36   19.48%
12/29/2025 Bernstein Courtney Breen $135.00 $124.56   8.38%
12/15/2025 Wolfe Research Alexandria Hammond $150.00 $120.41   24.57%
11/25/2025 BMO Capital Evan David Seigerman $135.00 $127.57   5.82%
11/24/2025 Truist Financial Gregory Renza $140.00 $127.91   9.45%
10/31/2025 Morgan Stanley Terence Flynn $147.00 $118.52   24.03%
10/09/2025 Cantor Fitzgerald Carter Gould $135.00 $118.25   14.16%
08/11/2025 Deutsche Bank James Shin $135.00 $118.83   13.61%
08/08/2025 Robert W. Baird Brian Skorney $108.00 $119.41   -9.56%
08/08/2025 Morgan Stanley Terence Flynn $143.00 $119.41   19.76%
07/14/2025 Leerink Partners David Risinger $114.00 $112.09   1.7%
06/18/2025 Morgan Stanley Terence Flynn $135.00 $108.00   25%
04/22/2025 Cantor Fitzgerald Carter Gould $125.00 $105.51   18.47%
03/11/2025 Morgan Stanley Terence Flynn $130.00 $114.43   13.61%
01/07/2025 RBC Capital Brian Abrahams $83.00 $90.63   -8.42%
11/07/2024 Piper Sandler Joseph Catanzaro $105.00 $90.09   16.55%
10/21/2024 BMO Capital Evan David Seigerman $94.00 $86.11   9.16%
10/21/2024 Leerink Partners Andrew Berens $96.00 $86.72   10.7%
10/18/2024 Morgan Stanley Terence Flynn $84.00 $87.07   -3.53%
09/23/2024 Jefferies Michael Yee $95.00 $83.76   13.42%
09/12/2024 Goldman Sachs Salveen Richter $71.00 $82.85   -14.3%
09/12/2024 Morgan Stanley Terence Flynn $79.00 $82.63   -4.39%
09/11/2024 Piper Sandler Joseph Catanzaro $95.00 $79.93   18.85%
08/14/2024 Truist Financial Asthika Goonewardene $83.00 $74.14   11.95%
08/09/2024 BMO Capital Evan David Seigerman $85.00 $75.59   12.45%
08/09/2024 RBC Capital Brian Abrahams $72.00 $75.59   -4.75%
07/08/2024 Raymond James Steven Seedhouse $93.00 $67.76   37.25%
06/24/2024 Jefferies Michael Yee $85.00 $71.24   19.31%
06/20/2024 Robert W. Baird Brian Skorney $80.00 $69.21   15.59%
06/17/2024 Mizuho Securities Salim Syed $90.00 $64.52   39.5%
06/14/2024 RBC Capital Brian Abrahams $74.00 $64.68   14.41%
05/20/2024 BMO Capital Evan David Seigerman $80.00 $67.90   17.82%
04/24/2024 HSBC Morten Herholdt $69.00 $67.08   2.86%
02/14/2024 RBC Capital Brian Abrahams $76.00 $73.53   3.36%
09/27/2023 RBC Capital Brian Abrahams $84.00 $75.90   10.67%
09/08/2023 Bank of America Securities Geoff Meacham $95.00 $75.92   25.13%
10/31/2022 Barclays Carter Gould $76.00 $79.27   -4.13%
10/28/2022 Truist Financial Robyn Karnauskas $91.00 $70.20   29.63%
10/27/2022 Robert W. Baird Brian Skorney $69.00 $79.27   -12.96%
02/28/2022 Jefferies Michael Yee $80.00 $59.50   34.45%
02/23/2022 Morgan Stanley Matthew Harrison $69.00 $59.85   15.29%
02/23/2022 UBS Colin Bristow $54.00 $59.85   -9.77%
02/03/2022 Atlantic Equities Steve Chesney $62.00 $63.10   -1.74%
02/02/2022 Oppenheimer Hartaj Singh $90.00 $64.57   39.38%
02/02/2022 Maxim Group Jason McCarthy $84.00 $64.57   30.09%
01/27/2022 Argus Research David Toung $75.00 $67.99   10.31%
12/05/2021 Goldman Sachs Salveen Richter $80.00 $67.94   17.75%
11/18/2021 Wedbush Robert Driscoll $67.00 $67.14   -0.21%
04/28/2021 J.P. Morgan Cory Kasimov $74.00 $61.14   21.03%

Gilead Sciences, Inc. FAQ's

Gilead Sciences, Inc. has been rated by research analysts at RBC Capital, Maxim Group, Morgan Stanley, Truist Financial, Jefferies, Barclays in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.